Allurion Technologies Inc. (ALUR)
NYSE · Healthcare
Allurion Technologies Inc. EBITDA 2022–2025
Allurion Technologies Inc. annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Allurion Technologies Inc. ebitda for the quarter ending March 31, 2026 was -3.6 M, a 49.71% decrease year-over-year.
- Allurion Technologies Inc. ebitda for the twelve months ending March 31, 2026 was -26.6 M, a 54.35% decrease year-over-year.
- Allurion Technologies Inc. annual ebitda for 2025 was -29.2 M, a 40.70% decrease from 2024.
- Allurion Technologies Inc. annual ebitda for 2024 was -49.2 M, a 37.19% decrease from 2023.
- Allurion Technologies Inc. annual ebitda for 2023 was -78.3 M, a 151.75% increase from 2022.
- Allurion Technologies Inc. annual ebitda for 2022 was -31.1 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Allurion Technologies Inc. EBITDA — FAQ
Allurion Technologies Inc. (ALUR) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALUR's ebitda history?
The chart and table above show Allurion Technologies Inc.'s ebitda by year and by quarter, including the growth rate.